Section Arrow
LXEO.NASDAQ
- Lexeo Therapeutics
Quotes are at least 15-min delayed:2025/01/11 17:55 EST
Last
 6.39
-0.43 (-6.30%)
Day High 
6.71 
Prev. Close
6.82 
1-M High
8.55 
Volume 
267.75K 
Bid
5.65
Ask
7.51
Day Low
6.1 
Open
6.66 
1-M Low
5.81 
Market Cap 
225.59M 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 6.83 
20-SMA 6.86 
50-SMA 7.32 
52-W High 22.33 
52-W Low 5.77 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-12.64/-4.40
Enterprise Value
234.62M
Balance Sheet
Book Value Per Share
4.21
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
0.02
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
CDTConduit Pharmaceuticals0.1233+0.0413+50.37%-- 
MRSNMersana Therapeutics0.72-0.58-44.62%-- 
TNXPTonix Pharmaceuticals Holding Corp.0.2787+0.0227+8.87%-- 
ZVSAZyVersa Therapeutics1.47+0.29+24.58%0PE
SANASana Biotechnology3.66-0.64-14.88%-- 
Quotes are at least 15-min delayed:2025/01/11 17:55 EST
Industry overview quotes are at least 15 minutes delayed
Business Description
Lexeo Therapeutics Inc is a a clinical-stage genetic medicines company dedicated to transforming healthcare by applying pioneering science to fundamentally change how disease is treated. Its pipeline consists of candidates targeting patient populations that place significant burden on society and are most amenable to their genetic medicine approach. The Company is focused on preclinical and clinical stage gene therapies, and specifically on hereditary and acquired diseases of high unmet need which is their only business segment.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.